Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Optiscan Imaging Limited ( (AU:OIL) ) has provided an update.
Optiscan Imaging Limited has entered into an exclusive collaboration agreement with Long Grove Pharmaceuticals to explore new applications for Long Grove’s fluorescein sodium contrast agent, AK-FLOUR®, in conjunction with Optiscan’s imaging technology. This partnership aims to expedite regulatory submissions and open new clinical and commercial opportunities, particularly in the U.S. market, by leveraging the strengths of both companies in pharmaceuticals and imaging technology.
More about Optiscan Imaging Limited
Optiscan Imaging Limited is a company specializing in fluorescence-based endomicroscopic imaging systems, primarily focusing on surgical applications. Their technology is used in combination with contrast agents to enhance imaging during medical procedures.
Average Trading Volume: 134,805
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$91.89M
See more insights into OIL stock on TipRanks’ Stock Analysis page.